Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6154083rdf:typepubmed:Citationlld:pubmed
pubmed-article:6154083lifeskim:mentionsumls-concept:C0038975lld:lifeskim
pubmed-article:6154083lifeskim:mentionsumls-concept:C0039195lld:lifeskim
pubmed-article:6154083lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:6154083lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:6154083lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:6154083lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:6154083lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:6154083lifeskim:mentionsumls-concept:C0456981lld:lifeskim
pubmed-article:6154083pubmed:issue4lld:pubmed
pubmed-article:6154083pubmed:dateCreated1980-6-16lld:pubmed
pubmed-article:6154083pubmed:abstractTextThe primary cytotoxic T lymphocyte (CTL) response to the SV40 tumor-associated specific antigen (TASA) has been analyzed in H-2 recombinant mice of the H-2b,d,f,k,q,and s haplotypes, in F1 hybrid mice (of each combination of these six independent haplotypes), and in intra-H-2 recombinant mice. A gradation of responsiveness to SV40 TASA in association with the various H-2 K/D alleles is reported. A weak response is found in association with the H-2 Dd allele, which is strongly affected by the responder status in association with the other H-2 K/D region determinants of the immunized host. Analysis of CTL from F1 mice, after secondary in vitro restimulation with SV40-transformed cells from either parental strain, indicates that in vivo priming to SV40 TASA in association with each K/D associative allele does occur, although efficient CTL are found only in association with specific H-2 K/D determinants after primary immunization. Mechanisms to explain host control of the ability to generate effector T cells to the TASA of this oncogenic virus are discussed.lld:pubmed
pubmed-article:6154083pubmed:languageenglld:pubmed
pubmed-article:6154083pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6154083pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6154083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6154083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6154083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6154083pubmed:statusMEDLINElld:pubmed
pubmed-article:6154083pubmed:monthAprlld:pubmed
pubmed-article:6154083pubmed:issn0022-1767lld:pubmed
pubmed-article:6154083pubmed:authorpubmed-author:PfizenmaierKKlld:pubmed
pubmed-article:6154083pubmed:authorpubmed-author:PanS HSHlld:pubmed
pubmed-article:6154083pubmed:authorpubmed-author:KnowlesB BBBlld:pubmed
pubmed-article:6154083pubmed:issnTypePrintlld:pubmed
pubmed-article:6154083pubmed:volume124lld:pubmed
pubmed-article:6154083pubmed:ownerNLMlld:pubmed
pubmed-article:6154083pubmed:authorsCompleteYlld:pubmed
pubmed-article:6154083pubmed:pagination1888-91lld:pubmed
pubmed-article:6154083pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6154083pubmed:meshHeadingpubmed-meshheading:6154083-...lld:pubmed
pubmed-article:6154083pubmed:meshHeadingpubmed-meshheading:6154083-...lld:pubmed
pubmed-article:6154083pubmed:meshHeadingpubmed-meshheading:6154083-...lld:pubmed
pubmed-article:6154083pubmed:meshHeadingpubmed-meshheading:6154083-...lld:pubmed
pubmed-article:6154083pubmed:meshHeadingpubmed-meshheading:6154083-...lld:pubmed
pubmed-article:6154083pubmed:meshHeadingpubmed-meshheading:6154083-...lld:pubmed
pubmed-article:6154083pubmed:meshHeadingpubmed-meshheading:6154083-...lld:pubmed
pubmed-article:6154083pubmed:meshHeadingpubmed-meshheading:6154083-...lld:pubmed
pubmed-article:6154083pubmed:meshHeadingpubmed-meshheading:6154083-...lld:pubmed
pubmed-article:6154083pubmed:meshHeadingpubmed-meshheading:6154083-...lld:pubmed
pubmed-article:6154083pubmed:meshHeadingpubmed-meshheading:6154083-...lld:pubmed
pubmed-article:6154083pubmed:meshHeadingpubmed-meshheading:6154083-...lld:pubmed
pubmed-article:6154083pubmed:meshHeadingpubmed-meshheading:6154083-...lld:pubmed
pubmed-article:6154083pubmed:meshHeadingpubmed-meshheading:6154083-...lld:pubmed
pubmed-article:6154083pubmed:meshHeadingpubmed-meshheading:6154083-...lld:pubmed
pubmed-article:6154083pubmed:meshHeadingpubmed-meshheading:6154083-...lld:pubmed
pubmed-article:6154083pubmed:year1980lld:pubmed
pubmed-article:6154083pubmed:articleTitlePreferential H-2 association in cytotoxic T cell responses to SV40 tumor-associated specific antigens.lld:pubmed
pubmed-article:6154083pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6154083pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6154083lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6154083lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6154083lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6154083lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6154083lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6154083lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6154083lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6154083lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6154083lld:pubmed